Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

Bibliographic Details
Main Authors: Marschner, Norbert, Arnold, Dirk, Engel, Erik, Hutzschenreuter, Ulrich, Rauh, Jacqueline, Freier, Werner, Hartmann, Holger, Frank, Melanie, Jänicke, Martina
Format: Online
Language:English
Published: Dove Medical Press 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408959/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408959/

Similar Items